Condition: Systemic Lupus Erythematosus · Sponsor: University Hospital, Bordeaux
The study aims at defining the role of ferroptosis s in the physiopathology of systemic lupus erythematosus (SLE). Ferroptosis (phenomenon of cellular death regulated by iron) is a metabolic pathway potentially implicated in SLE with potential for the discovery of new therapeutic strategies.
This description comes directly from the study's public registry record.
Christophe RICHEZ, Prof · (0)5 56 79 55 56 · christophe.richez@chu-bordeaux.fr
Thomas BARNETCHE, PhD · (0)5.57.82.04.93 · thomas.barnetche@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU de Bordeaux - service de rhumatologie | Bordeaux, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07260942